Literature DB >> 6542467

Clinical symptoms and IgE responses to common food proteins in atopic and healthy children.

G Hattevig, B Kjellman, S G Johansson, B Björkstén.   

Abstract

The appearance of symptoms suggestive of allergy through the first 4 years of life was studied prospectively in eighty-six healthy newborn babies. Blood samples were obtained at birth, at 3, 8, 25 and 48 months of age and analyzed for levels of total serum IgE and for IgE antibodies to some common foods. The occurrence of IgE antibodies was related to atopic manifestations and to a detailed history of infant feeding and family history of allergy. All infants with elevated cord blood IgE (more than 1.3 kU/l) developed manifestations of atopy. Specific IgE antibodies against egg, cow's milk and soy were demonstrated at 3, 8, 25 and 48 months in nine, twenty-three, six and two children respectively. Egg was a more potent sensitizing agent than cow's milk, IgE antibodies to egg being present in thirty-one samples, to cow's milk in eleven and to soy in five samples. Nine infants developed IgE antibodies to eggs or cow's milk before the introduction of these nutrients into the food. The IgE antibody levels were generally low in healthy non-atopic children and did, with one exception, not reach RAST class 1. In contrast, the levels of IgE antibodies to egg or cow's milk were higher in eleven blood samples from atopic children. We conclude that transient low IgE antibody responses to food proteins appear relatively often even in healthy infants. High concentrations of IgE antibodies however are almost exclusively seen in infants with atopic disease. Sensitization may appear early in infancy sometimes even before the offending food has been introduced into the diet.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6542467     DOI: 10.1111/j.1365-2222.1984.tb02243.x

Source DB:  PubMed          Journal:  Clin Allergy        ISSN: 0009-9090


  11 in total

1.  Extensively and partially hydrolysed infant formulas for allergy prophylaxis.

Authors:  G Oldaeus; K Anjou; B Björkstén; J R Moran; N I Kjellman
Journal:  Arch Dis Child       Date:  1997-07       Impact factor: 3.791

Review 2.  Can persistent IgE responses be suppressed?

Authors:  D M Kemeny; D Diaz-Sanchez
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

Review 3.  Prediction of the development of IgE-mediated atopic disorders and environmental engineering for their control.

Authors:  B A Chowdhury; R K Chandra
Journal:  Clin Rev Allergy       Date:  1989

Review 4.  Strategies for prevention.

Authors:  Y Vandenplas
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

5.  The sensitivity of rat CD8+ and CD4+ T cells to ricin in vivo and in vitro and their relationship to IgE regulation.

Authors:  D Diaz-Sanchez; D M Kemeny
Journal:  Immunology       Date:  1990-01       Impact factor: 7.397

6.  Immediate hypersensitivity to ovalbumin in children with hen's egg white allergy.

Authors:  S Lau; M Thiemeier; R Urbanek; M Kemeny; U Wahn
Journal:  Eur J Pediatr       Date:  1988-08       Impact factor: 3.183

7.  Season of birth as predictor of atopic manifestations.

Authors:  L Nilsson; B Björkstén; G Hattevig; B Kjellman; N Sigurs; N I Kjellman
Journal:  Arch Dis Child       Date:  1997-04       Impact factor: 3.791

Review 8.  A comprehensive review of sensitization and allergy to soy-based products.

Authors:  Yitzhak Katz; Pedro Gutierrez-Castrellon; Manuel Gea González; Rodolfo Rivas; Bee Wah Lee; Pedro Alarcon
Journal:  Clin Rev Allergy Immunol       Date:  2014-06       Impact factor: 8.667

9.  Egg and cows' milk hypersensitivity in exclusively breast fed infants with eczema, and detection of egg protein in breast milk.

Authors:  A Cant; R A Marsden; P J Kilshaw
Journal:  Br Med J (Clin Res Ed)       Date:  1985-10-05

10.  The long-term effect of a partial whey hydrolysate formula on the prophylaxis of atopic disease.

Authors:  Y Vandenplas; B Hauser; C Van den Borre; C Clybouw; T Mahler; S Hachimi-Idrissi; L Deraeve; A Malfroot; I Dab
Journal:  Eur J Pediatr       Date:  1995-06       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.